Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 4/2012

01.08.2012 | Original Article

Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion

verfasst von: Katsumi Shigemura, Kazushi Tanaka, Minori Matsumoto, Yuzo Nakano, Toshiro Shirakawa, Masahiro Miyata, Masuo Yamashita, Soichi Arakawa, Masato Fujisawa

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the association between prophylactic antibiotic administration (PAA) and post-operative infection in radical cystectomy with orthotopic neobladder urinary diversion carried out for patients with bladder cancer. Fifty-seven consecutive cases were analyzed retrospectively. Post-operative infections were categorized as urinary tract, wound, and remote infections. We used the antibiotics tazobactam/piperacillin (TAZ/PIPC), sulbactam/ampicillin (SBT/ABPC), flomoxef (FMOX), cefazolin (CEZ), cefotiam (CTM), and cefmetazole (CMZ). Twenty-five (43.9%) patients had post-operative infections. Five of these (8.77%) patients had wound infections, 22 (38.6%) patients had urinary tract infections, and 2 (3.51%) had remote infections. Our statistical analysis demonstrated that the patients with TAZ/PIPC used for PAA (5/18: 27.8%) had a significantly lower post-operative infection rate than patients with other antibiotics (24/39: 61.5%) (p = 0.0442). In addition, the patients with a shorter-duration PAA (within 72 h after the operation (48–72 h)) had a significantly lower rate of post-operative infections (12/33: 36.4%) than those with longer-duration PAA (longer than 72–96 h after the operation) (16/24: 66.7%) (p = 0.0239). Taken together, these results suggest that TAZ/PIPC with shorter PAA duration (within 72 h) might lead to a lower rate of post-operative infections. In conclusion, our data showed that PAA with TAZ/PIPC with a shorter duration PAA (within 72 h) might be recommended for radical cystectomy with orthotopic neobladder reconstruction. A prospective study based on our data is desirable to establish or revise guidelines for prophylactic medication for preventing post-operative infection after radical cystectomy with orthotopic neobladder urinary diversion.
Literatur
1.
Zurück zum Zitat Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, et al. Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure. Hinyokika Kiyo. 2009;55:75–8.PubMed Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, et al. Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure. Hinyokika Kiyo. 2009;55:75–8.PubMed
2.
Zurück zum Zitat Hara N, Kitamura Y, Saito T, Komatsubara S, Nishiyama T, Takahashi K. Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: efficacy and risk of antimicrobial prophylaxis on the operation day alone. Int J Urol. 2008;15:511–5.PubMedCrossRef Hara N, Kitamura Y, Saito T, Komatsubara S, Nishiyama T, Takahashi K. Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: efficacy and risk of antimicrobial prophylaxis on the operation day alone. Int J Urol. 2008;15:511–5.PubMedCrossRef
3.
Zurück zum Zitat Iwai S. Clinically isolated bacterii seen in complicated infections. Nippon Geka Gakkai Zasshi. 1996;97:1091–6.PubMed Iwai S. Clinically isolated bacterii seen in complicated infections. Nippon Geka Gakkai Zasshi. 1996;97:1091–6.PubMed
4.
Zurück zum Zitat Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K, et al. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol. 2007;14:890–909.PubMedCrossRef Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K, et al. Japanese guidelines for prevention of perioperative infections in urological field. Int J Urol. 2007;14:890–909.PubMedCrossRef
5.
Zurück zum Zitat Kanamaru S, Terai A, Ishitoya S, Kunishima Y, Nishiyama H, Segawa T, et al. Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: a preliminary study. Int J Urol. 2007;11:355–63.CrossRef Kanamaru S, Terai A, Ishitoya S, Kunishima Y, Nishiyama H, Segawa T, et al. Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: a preliminary study. Int J Urol. 2007;11:355–63.CrossRef
6.
Zurück zum Zitat Pourmand G, Abedi AR, Karami AA, Khashayar P, Mehrsai AR. Urinary infection before and after prostatectomy. Saudi J Kidney Dis Transpl. 2010;21:290–4.PubMed Pourmand G, Abedi AR, Karami AA, Khashayar P, Mehrsai AR. Urinary infection before and after prostatectomy. Saudi J Kidney Dis Transpl. 2010;21:290–4.PubMed
7.
Zurück zum Zitat Trinchieri A, Paparella S, Cappoli S, Esposito N, Butti A, Vaiani R, et al. Prospective assessment of the efficacy of the EAU guidelines for the prevention of nosocomial acquired infections after genitourinary surgery in a district hospital. Arch Ital Urol Androl. 2009;81:46–50.PubMed Trinchieri A, Paparella S, Cappoli S, Esposito N, Butti A, Vaiani R, et al. Prospective assessment of the efficacy of the EAU guidelines for the prevention of nosocomial acquired infections after genitourinary surgery in a district hospital. Arch Ital Urol Androl. 2009;81:46–50.PubMed
8.
Zurück zum Zitat Studer UE, Spiegel T, Casanova GA, Springer J, Gerber E, Ackermann DK, et al. Ileal bladder substitute: antireflux nipple or afferent tubular segment? Eur Urol. 1991;20:315–26.PubMed Studer UE, Spiegel T, Casanova GA, Springer J, Gerber E, Ackermann DK, et al. Ileal bladder substitute: antireflux nipple or afferent tubular segment? Eur Urol. 1991;20:315–26.PubMed
9.
Zurück zum Zitat Reddy PK. Detubularized sigmoid reservoir for bladder replacement after cystoprostatectomy. Urology. 1987;29:625–8.PubMedCrossRef Reddy PK. Detubularized sigmoid reservoir for bladder replacement after cystoprostatectomy. Urology. 1987;29:625–8.PubMedCrossRef
10.
Zurück zum Zitat Reddy PK, Lange PH, Fraley EE. Total bladder replacement using detubularized sigmoid colon: technique and results. J Urol. 1991;145:51–5.PubMed Reddy PK, Lange PH, Fraley EE. Total bladder replacement using detubularized sigmoid colon: technique and results. J Urol. 1991;145:51–5.PubMed
11.
Zurück zum Zitat Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–132.PubMedCrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–132.PubMedCrossRef
12.
Zurück zum Zitat Quek ML, Stein JP, Daneshmand S, Miranda G, Thangathurai D, Lieskovsky G, et al. A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006;175:886–9.PubMedCrossRef Quek ML, Stein JP, Daneshmand S, Miranda G, Thangathurai D, Lieskovsky G, et al. A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006;175:886–9.PubMedCrossRef
13.
Zurück zum Zitat Esposito S. Immune system and surgical site infection. J Chemother. 2001;13:12–6.PubMed Esposito S. Immune system and surgical site infection. J Chemother. 2001;13:12–6.PubMed
14.
Zurück zum Zitat Takeyama K, Matsukawa M, Kunishima Y, Takahashi S, Hotta H, Itoh N, et al. Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion. J Infect Chemother. 2005;11:177–81.PubMedCrossRef Takeyama K, Matsukawa M, Kunishima Y, Takahashi S, Hotta H, Itoh N, et al. Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion. J Infect Chemother. 2005;11:177–81.PubMedCrossRef
15.
Zurück zum Zitat Sumiyama Y, Arima Y. Surgical site infection: SSI. Nippon Rinsho. 2002;60:2204–9.PubMed Sumiyama Y, Arima Y. Surgical site infection: SSI. Nippon Rinsho. 2002;60:2204–9.PubMed
16.
Zurück zum Zitat Hamasuna R, Betsunoh H, Sueyoshi T, Yakushiji K, Tsukino H, Nagano M, et al. Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Int J Urol. 2004;11:941–7.PubMedCrossRef Hamasuna R, Betsunoh H, Sueyoshi T, Yakushiji K, Tsukino H, Nagano M, et al. Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Int J Urol. 2004;11:941–7.PubMedCrossRef
17.
Zurück zum Zitat Kyoda Y, Takahashi S, Takeyama K, Masumori N, Tsukamoto T. Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy. J Infect Chemother. 2010;16:118–22.PubMedCrossRef Kyoda Y, Takahashi S, Takeyama K, Masumori N, Tsukamoto T. Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy. J Infect Chemother. 2010;16:118–22.PubMedCrossRef
18.
Zurück zum Zitat Montesino Semper M, González Santiago, de Garibay A, Ruiz Ramo M, Hualde Alfaro A, Jiménez Calvo J, de Pablo Cárdenas A, et al. Camey II type orthotopic bladder replacement and its complications: 10-year experience. Actas Urol Esp. 2001;25:99–104.PubMed Montesino Semper M, González Santiago, de Garibay A, Ruiz Ramo M, Hualde Alfaro A, Jiménez Calvo J, de Pablo Cárdenas A, et al. Camey II type orthotopic bladder replacement and its complications: 10-year experience. Actas Urol Esp. 2001;25:99–104.PubMed
19.
Zurück zum Zitat Wullt B, Holst E, Steven K, Carstensen J, Pedersen J, Gustafsson E, et al. Microbial flora in ileal and colonic neobladders. Eur Urol. 2004;45:233–9.PubMedCrossRef Wullt B, Holst E, Steven K, Carstensen J, Pedersen J, Gustafsson E, et al. Microbial flora in ileal and colonic neobladders. Eur Urol. 2004;45:233–9.PubMedCrossRef
20.
Zurück zum Zitat van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis. 2005;11:865–71.PubMedCrossRef van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis. 2005;11:865–71.PubMedCrossRef
21.
Zurück zum Zitat Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1, 000 neobladders: the 90-day complication rate. J Urol. 2010;184:990–4.PubMedCrossRef Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1, 000 neobladders: the 90-day complication rate. J Urol. 2010;184:990–4.PubMedCrossRef
22.
Zurück zum Zitat Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:247–78.CrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:247–78.CrossRef
Metadaten
Titel
Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion
verfasst von
Katsumi Shigemura
Kazushi Tanaka
Minori Matsumoto
Yuzo Nakano
Toshiro Shirakawa
Masahiro Miyata
Masuo Yamashita
Soichi Arakawa
Masato Fujisawa
Publikationsdatum
01.08.2012
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 4/2012
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0360-9

Weitere Artikel der Ausgabe 4/2012

Journal of Infection and Chemotherapy 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.